3 Results for "

myasthenia gravis model

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "myasthenia gravis model" in MCE Product Catalog:

Cat. No.: HY-158183
CAS No.: 2354321-33-6
Purity:  99.60%
Synonyms: NMD670
Target:  

Chloride Channel

Research Areas:  

Neurological Disease

NMD670 is an orally active inhibitor of skeletal muscle specific chloride channel ClC-1 with an EC50 of 1.6 μM. NMD670 enhances neuromuscular transmission and improves muscle contraction and strength. NMD670 can be used in the study of muscle weakness and muscle fatigue .
loading...
    loading...
Cat. No.: HY-P990302

Target:  

nAChR

Research Areas:  

Inflammation/Immunology

Anti-Human/Rat/Fish AChR Antibody (Mab35) is an anti-human/rat/fish AChR IgG1 monoclonal antibody. Anti-Human/Rat/Fish AChR Antibody (Mab35) can attack the AChR of neuromuscular junctions. Anti-Human/Rat/Fish AChR Antibody (Mab35) can be used for the construction of myasthenia gravis models .
loading...
    loading...
Cat. No.: HY-10540
CAS No.: 908351-31-5
Synonyms: AEB071 acetate
Target:  

PKC NF-κB

Research Areas:  

Inflammation/Immunology

Sotrastaurin (AEB071) acetate is a selective, orally active PKC inhibitor. Sotrastaurin acetate inactivates NF-κB by inhibiting PKC α, β, θ, γ subtypes, thereby reducing the transcription levels of immune response-related genes. Sotrastaurin acetate effectively inhibits alloreactive T cell proliferation, conventional T cell activation, as well as the production of pro-inflammatory cytokines and B lymphocytes. Sotrastaurin acetate also maintains the functional and phenotypic stability of regulatory T cells, enhances Foxp3 expression and restores the balance of helper T lymphocytes. Sotrastaurin acetate can prolong the survival time of allografts, and alleviate inflammatory responses and myasthenic symptoms by reducing anti-AChR antibody levels. Sotrastaurin acetate is widely used in studies related to kidney transplantation, psoriasis and myasthenia gravis .
loading...
    loading...